Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Neuro-Oncology
•
Medical Oncology
•
Neurology
How do you manage follow up for patient who was diagnosed with pineal gland germinomas with drop metastatic to the spinal cord?
Related Questions
Would patients receiving targeted therapies be eligible for TTFields for brain metastases?
How would you approach a patient with recurrent grade 3 oligodendroglioma (MGMT-methylated, IDH mutant, 1p/19q co-deleted) 1 year after gross total resection and adjuvant chemotherapy and radiation?
How will you select patients with brain metastases for TTFields?
How well does a negative non-contrast MRI of the brain exclude metastasis in a patient with squamous cell carcinoma of the lung?
What are your top takeaways in Neuro Oncology from ASCO 2025?
How do you counsel glioblastoma multiforme patients on which types of clinical trials to pursue?
Is there a role for bevacizimab (IV or IA) for steroid refractory radionecrosis for AVM?
In what circumstances would you consider use of IDH inhibitors in high-grade astrocytomas?
Would you consider adding gabapentin off label for use in the treatment of glioblastoma at this time?
Do you utilize tumor treating fields in patients with anaplastic pleomorphic xanthoastrocytoma (PXA) III?
